PeptideStack
5.2kquestions
20kanswers
220users

How is a beyond-use date set for compounded liraglutide in bacteriostatic water?

Asked 8 Nov 2024Modified 17 months agoViewed 38k times
30

The specifics, since they change the answer: liraglutide · bacteriostatic water.

I want a method I can write down and repeat, not a rule of thumb.

I would rather over-engineer this than discover a problem later, within reason.

So: what is the actual procedure, and which steps matter as opposed to being ritual?

compounding
compounding

Compounded preparations: what a 503A and a 503B facility may legally prepare and when, base versus salt forms, beyond-use dating under USP…

61 questions
shelf-life
shelf-life

How long a preparation remains within specification: labelled expiry for a sealed lyophilised vial, beyond-use dating after reconstitution, and…

327 questions
bacteriostatic-water
bacteriostatic-water

Water for injection containing roughly 0.9 per cent benzyl alcohol as a bacteriostatic agent. It suppresses growth in a multiple-withdrawal vial;…

149 questions
liraglutide
liraglutide

A once-daily GLP-1 receptor agonist and the compound that established the class. Still relevant for its shorter half-life, its paediatric and…

235 questions
shareeditfollowflag
OK
askedoona_kekkonen13k178 Nov 2024

5 Answers

Accepted answer first, then by votes
38

Accepted answer

Answer first: a compounded preparation is made for an individual under a prescription and is not an approved product, so it carries neither the release testing nor the pharmacovigilance of one.

Beyond-use dates on compounded sterile preparations are set by standards that depend on the preparation environment and are much shorter than a manufactured product's shelf life.

The relevant detail is that facility quality varies enormously and is the practical determinant of what you receive. The relevant questions are about sterility assurance, potency testing and beyond-use dating.

Regulatory warnings have specifically addressed salt forms differing from the approved active moiety in this therapeutic area.

Ask for the certificate of analysis on the lot. A serious facility has one.

shareimprove this answerflag
OB
answered · acceptedone_ml_bac18k2723 Nov 2024
Sponsored

Sigma-Aldrich - Certified Reference Materials

Analytical standards and reagents with traceable certificates. Every quantitative result you read inherits the accuracy of the standard behind it.

Shop standards
29

The short version: legitimate under a prescription within defined limits, unapproved by definition, and quality depends entirely on the facility.

Regulators generally prohibit compounding what is essentially a copy of a commercially available product, with a shortage listing being the usual exception that permits it temporarily.

Salt forms matter: a compounded preparation using a different salt from the approved product is not the same active moiety, and that has been the specific object of regulatory warnings.

The caveat is that the legal and regulatory position differs by jurisdiction and nothing here is legal advice.

The framework is jurisdiction-specific. Check yours rather than a general answer.

shareimprove this answerflag
ED
answerede_dziedzic51k1475 Dec 2024
13

Worth being precise here: this is an area where the legal position and the quality question are separate and both matter.

Compounding is the preparation of a medicine for an individual patient in response to a prescription, where an approved product is unsuitable. It sits outside the approval framework by design rather than by omission.

Stated carefully, a compounded preparation has no marketing authorisation, no batch release by a qualified person and no pharmacovigilance obligation attached to it. That is the structural difference from a licensed product.

Beyond-use dating for compounded sterile preparations is governed by published standards keyed to the compounding environment.

Nothing here is medical advice.

Check the beyond-use date and what it was based on.

shareimprove this answerflag
CF
answeredclaudia_ferrante22k2712 Nov 2024
11

The relevant distinction is between compounding for an individual patient and compounding at scale, which are regulated differently.

Additives are the other divergence. Preparations combining an active with vitamins or other agents are not equivalent to the approved product and have not been studied in that combination.

Compounding is defined in regulation as preparation for an individual patient under prescription and is distinguished from manufacturing by scale and by the patient-specific requirement.

A compounded preparation is unapproved by definition, which is a statement about the framework rather than about the facility.

Ask which salt form. A different salt is a different active moiety.

shareimprove this answerflag
DC
answereddrawn_and_capped12k171 Mar 2025
7The indication mattering more than the molecule is the part people find hardest to believe. – assay_blank 5 months ago
8Any figure for how often peer-to-peer review resolves a denial? It seemed high when I did it. – sian_llewellyn 7 months ago
add a comment
8

The honest answer is that a well-run compounding pharmacy is a serious operation and that the variance across facilities is wide.

Ask for the certificate of analysis on the compounded lot. A serious facility will have one; the request itself is informative.

Prohibitions on compounding essential copies of commercially available products are explicit in the relevant regulatory frameworks, with shortage listings as the usual exception.

Facility quality is the dominant variable and cannot be assessed from a website.

Compounded means unapproved by definition. That is structural, not pejorative.

shareimprove this answerflag
CH
answeredcal_hennessy17k2718 Jan 2025

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.